key: cord-0813998-z42rf20o
authors: Basu, Jayati Kusari; Chauke, Lawrence; Magoro, Terrance
title: Clinical Features and Outcomes of COVID-19 Infection among Pregnant Women in South Africa
date: 2021-06-28
journal: Int J MCH AIDS
DOI: 10.21106/ijma.479
sha: 96dc7ddd25d5beb1c138f2af41077dcdad806f55
doc_id: 813998
cord_uid: z42rf20o

BACKGROUND AND OBJECTIVE: Studies among COVID positive pregnant women are limited. Previous studies reported high rate of symptoms, comorbidities and poor fetal/neonatal outcome among women of different ethnicity. To date, no study was reported among pregnant African women. This study was conducted to determine the clinical features and outcomes of COVID-19 positive pregnant women in Ekurhuleni District in South Africa. METHODS: Retrospective record review of 103 COVID-19 infected pregnant women during the period of April to September 2020 was done. Clinical features, symptoms, comorbidities, laboratory results, maternal and neonatal outcomes were analyzed. Descriptive statistics (mean + standard deviation, number and percentages) and inferential statistics (Chi-square test) were calculated. Ethical clearance was obtained from the Human Research Ethics Committee of the University of Witwatersrand, South Africa. RESULTS: Majority (90%) were of African ethnicity and symptomatic (53%). The commonest symptom, comorbidity and laboratory abnormality was cough (62%), hypertension (23%) and high LDH (20%), respectively. Thrombocytopenia and lymphocytopenia occurred among 9% and 15% of the women, respectively. Although association was not significant, symptoms were more common among comorbid, HIV positive and women with abnormal results. Commonest complications were preterm labor (8%) and macerated stillbirths (6%). Six (6%) mothers died. CONCLUSION AND GLOBAL HEALTH IMPLICATIONS: COVID positive pregnant South African women were commonly symptomatic but incidence of adverse fetal outcomes was low. High rate of preterm labor, macerated stillbirths and maternal deaths was a concern. This study has several strengths. It included all COVID positive women over a 6 months’ period at all level of healthcare facilities such as clinics, community health centers/midwifery units, and district, regional and tertiary hospitals, conducted in an African country. Previous studies included mainly hospitals raising a high probability of including mainly severely ill women. The study might benefit the health care workers in other African countries.

South Africa has recorded the highest number of COVID-19 infections in Africa. 1 COVID-19 infected patients can be asymptomatic or symptomatic, the symptoms are of varying severity. The most common symptoms are dry cough, fever, sore throat, tiredness and myalgia. Less common symptoms are conjunctivitis, diarrhea, nasal congestion and headache. 2 Asymptomatic or mild disease is characterized by having oxygen saturation ≥ 95% on room air, respiratory rate <25/minute, heart rate <120/minute, temperature 36-39°C and normal mental status. 3 In symptomatic patients, COVID-19 symptoms usually appear by 11.5 days in 97.5% patients and the median incubation period is 5 days, hence the recommended 14-days quarantine period. 4 Certain hematological changes were observed among symptomatic patients; among these, thrombocytopenia and lymphocytopenia were common. 5 High lactic dehydrogenase (LDH) level was found to be a predictor of disease severity. 6 Investigations should be done depending on the severity of the disease. Asymptomatic mild disease at the least might require a Human Immuno Deficiency Virus (HIV) testing. If HIV positive, a sputum testing to exclude tuberculosis is recommended. 7 About 80% of the infected people do not require any hospital treatment. The World Health Organization and the South African National Institute for Communicable Diseases (NICD) recommended 14 days' isolation for positive cases with mild or no symptoms. However, the duration has been reduced to 10 days with emergence of new information. Isolation can be done at patient's home or at a designated isolation facility if patient is unable to self-isolate at home. Repeat testing was not recommended at the end of the 10 days' period. 2, 8 Globally, there are very few reports on COVID-19 infection among pregnant women limiting the knowledge of disease process among this group. Compared to the general population, limited evidence suggested that pregnant women are not at higher risk of infection and worse maternal outcome. 7 In a study in United States of America (USA) including 43 COVID-19 positive pregnant women, 37 (86%) exhibited mild disease, four (9.3%) had severe disease, and two (4.7%) critical disease. 9 The most common symptoms among 15 pregnant Chinese women were fever (86.7%) and cough (60%) and symptoms were mild. Lymphocytopenia was most common (80%) abnormal laboratory finding. 10 Another study in China did not find any differences in clinical features between nine pregnant women and the general population. In this study, fever was the commonest (78%) symptom followed by cough (44%), sore throat (22%), and myalgia (33%). Lymphocytopenia was found in 55% of the patients. 11 Another study in China comparing 41 pregnant women with 14 non-pregnant adults, reported that pregnant women were more likely to present with normal temperature, and lymphocytopenia than nonpregnant adults. 12 On the contrary, a retrospective study on 116 pregnant women in China found that majority (76.7%) were symptomatic. The most common symptoms were fever (50.9%) followed by cough (28.4%). Eight (6.9%) had severe pneumonia but no maternal deaths. 13 South Africa has nine provinces of which Gauteng is the smallest but has the largest population density (15.2 million, 26% of total population). 14 Each province has a well-developed district health system. Among the five districts under Gauteng province, Ekurhuleni Health District (EHD) is the second most densely populated (about 3.9 million). 15 Gauteng had 219,704 infected cases and 4, 244 deaths by September 30, 2020. 16 EHD had 48, 116 cases and 785 deaths by September 30, 2020, implicating the death rate of about 2%. 17 EHD has six hospitals: one tertiary, four regional and one district hospital, and eight community health centers providing antenatal, labor, and postnatal care. Additionally, 95 primary health care clinics provide antenatal and postnatal care. All healthcare facilities followed the NICD guidelines for COVID-19 screening, testing, and management. 7,8 Furthermore, EHD established three COVID isolation centers where mostly asymptomatic and mildly symptomatic COVID-19 positive patients (who are unable to selfisolate and do not require admission at hospitals) are admitted. Doctors and nursing sisters provide a 24-hour clinical services at these centers.

Although screening was universal, testing was done for the history of international travel, history of contact, suggestive symptoms, and at the discretion of attending health care workers. All regional hospitals implemented universal testing for all women that were admitted for cesarean sections. Women who were sent home for self-isolation were monitored telephonically by the nearest health care facilities. Women admitted in hospitals for COVID-19 related morbidity or obstetrics reasons were discharged when recovered and isolated at home or at COVID centers to complete the isolation period. There was a district of COVID-19 management team where all health care facilities and COVID centers reported all COVID positive patients on a daily basis. All health care facilities and COVID centers kept a register of COVID-19 positive patients where all information about the patients were recorded. Maternity case records (MCR) which contains antenatal, intrapartum and postpartum information, are used for all pregnant women in SA. MCRs are kept in CHCs and hospitals after the women are discharged following delivery.

To date, there are no African studies done on COVID-19 positive pregnant women. The aim of this study was to determine the clinical features and outcome of COVID-19 infection among COVID-19 positive pregnant women within the EHD, SA.

COVID registers and MCRS of all COVID positive pregnant and postpartum women at the EHD, SA during the period of April to September 2020 were retrospectively reviewed. The study obtained ethical clearance from the Human Research Ethics Committee of the University of Witwatersrand, Ekurhuleni district research committee, Gauteng provincial research committee and all participating health care facilities. All women were included and none were excluded due to pandemic status of the disease. Investigations related to COVID-19 were not done in mildly symptomatic and asymptomatic women. Results of investigation and detailed information were not available for some of the privately booked patients as private medical practitioners did not disclose their patients' information. Record keeping at the facilities were not complete at times. As a result, the sample size was not uniform for all variables. Comorbid conditions were diagnosed by the attending healthcare workers.

Data was collected using a data collection tool created by researcher. Data included demographic information such as age, ethnicity, and place of isolation/admission. Obstetrics factors such as parity, pregnancy status (antenatal or postnatal), antenatal complications and gestational age (GA) at delivery were also included. COVID-19 related factors such as GA at COVID-19 diagnosis, reason for testing, travel history, history of contact, symptoms, comorbidity and blood results (platelets, lymphocytes and LDH), maternal and neonatal outcomes, were also included. HIV result was included as recommended. 7 Statistical analysis was done by Pass software (NCSS, Kayesville, UT, USA). Descriptive statistics included mean with standard deviation (SD), actual number and percentages. Inferential statistics included Chi-square test, used to determine if there was any association between symptoms and other variables such as comorbidity, HIV status and abnormal laboratory results. P value of less than 0.05 was considered statistically significant.

The study included 103 COVID-19 positive pregnant and postpartum women. EHD had 48, 116 COVID positive cases among general population. 17 Therefore, pregnant women contributed 0.21% (103/48,116) of the total infections. Ninety-three (90%), 2 (2%) and 8 (8%) were African, Caucasian and mixed ethnicity women respectively. Age and parity are described (Table 1) . Employment status was available for 96 women. Forty-six (48%) and 50 (52%) of the women were employed and unemployed respectively.

A total of 99 (96%) women were booked. Four (4%) women never initiated antenatal care. Mean (± SD) gestational age (GA) at booking was 16.8 (SD ± 6.10) weeks with a range of 6-33 weeks. Majority of the women booked in 2 nd trimester (Table 1) .

Majority (33, 32%) of the women were admitted in the hospital for various reasons (symptomatic, planned cesarean section and obstetrics complications) to complete isolation period (Table 1) . Ninety (87%), 12 (12%) and one (1%) woman was antenatal, postpartum and post-miscarriage at the time of COVID-19 diagnosis respectively. The mean GA at the time of diagnosis was 32 (+ 9.02) weeks.

Twenty-four (44%) women had single symptoms and 31 (56%) presented with multiple symptoms. Symptoms were categorized by mild (having normal vital signs and receiving only symptomatic treatment or no treatment), moderate (requiring hospital admission) and severe (high care or intensive care unit admission) ( Table 2 ).

Seventy-three (71%) women had no comorbidities and two had multiple comorbidities (Table 1) . Among 30 (29%) women who had comorbidities, 16 (53%) were symptomatic and 14 (47%) had no symptoms. A Chi-square test showed no significant (P = 0.67) association between comorbidity and symptoms. Among 30 of the women who had comorbidities, hypertension was the commonest (80%) followed by Diabetes Mellitus (13%), morbid obesity (3%) and cancer (3%).

Ninety-nine (96%) women underwent HIV testing, of which 61 (62%) and 38 (38%) tested HIV negative and positive respectively. Twenty-one (55%) of the HIV positive women were symptomatic. Thirty-two (52%) of the HIV negative women were symptomatic. Association between HIV positivity and symptoms was not significant (P = 0.83).

Thrombocytopenia of seven (9%), High LDH counts of four (20%) and lymphocytopenia of three (15%) women who had no comorbidities could be attributed to COVID (Table 3) . Comorbidities might affect the Platelets, Lymphocytes and LDH count. Therefore, only women who had abnormal results but no comorbidities, were included for interpreting the abnormal results. Among nine women who had thrombocytopenia, six (67%) were symptomatic and the association was not significant (Chi-square test, p = 0.30). Among four women who had lymphocytopenia, all (100%) were symptomatic and it was not significant (Chi-square test, p = 0.26). Among eight women who had high LDH count, six (75%) were symptomatic and it was not significant (Chi-square test, p = 1).

Fifteen (15%) mothers and four (4%) fetuses had antenatal complications. Among 15 women who had complications, preterm labor (PTL) was the commonest (53%) complication followed by anemia (20%), abruption placenta (13%), preterm rupture of membrane (7%) and miscarriage (7%). Among four fetuses who had complications, two (50%) had intrauterine growth retardation (IUGR) and remaining two (50%) had intra-uterine fetal deaths (Table 3) . A Chi-square test between comorbidities (Hypertension, Diabetes mellitus) and outcome (PTL, Anemia, abruption placenta, PPROM) showed no significant association between comorbidity and outcomes.

Sixty-eight women delivered 69 babies (one twin). Mean (+ SD) GA at delivery was 38.42 (+ 2.30) weeks.

Twenty-four (35%) women delivered vaginally. Forty-four (65%) had cesarean section (CS), of which 32 (78%) had planned CS and 12 (22%) had emergency CS.

The mean (+ SD) weight of the neonates was 3,060 (+ 566.59) grams. Among six (9%) neonates who had poor outcomes, two (33%) babies had poor Apgar scores at 5 minutes and four (66%) babies were macerated still born. A Chi-square test between comorbidity (hypertension and Diabetes) and neonatal outcomes was not significant.

Six (6%) mothers died and 97 (94%) women were discharged in a healthy condition. 

This study on COVID-19 positive pregnant women in SA, has similarities and differences to other studies.

This is the first study where majority (90%) were of African ethnicity. Most of the published studies had different ethnic population. This study had three (3%) teenagers which was not found in other studies. 12, 13, 14, 15 This might have reflected the challenge of teenage pregnancies in African countries. Majority (83%) were multigravida which was different from the 55% of primigravidae reported in another study. 16 Other studies did not report parity hence difficult to compare if parity has any association with COVID-19 infection in pregnancy.

In order to understand testing coverage in different level of health care facilities, reasons for COVID testing were analyzed. Majority (53%) were tested for symptoms followed by testing for elective cesarean section (28%). Majority (87%) were diagnosed during the antenatal period which was different from other studies where majority of infections were reported during the postpartum period. 12, 13, 16 This difference might de due to the indications for testing.

The study observed higher rate (47%) of asymptomatic women than that (13% to 33%) of other studies. 12, 13, 18 Although majority (62%) were mildly symptomatic in this study, other studies had much higher rate of mild disease (86% -93%). 9, 13, 18 Majority of the women presented with cough (62%) in this study while fever was found to be the commonest symptom in other studies. 18, 19 

Thirty (29%) women had comorbidities. Studies reported varying rate (22% to 34%) of comorbidities including antepartum hemorrhage, polycystic ovary and hypothyroidism, which might not have relevance for COVID-19. 18, 19 Incidence of hypertension (23%) was similar to other studies (25%/23%) 18, 19 and also higher (7%) than other studies. 12 The incidence of Diabetes mellitus was lower (4%) than reported (20%) in other studies. 19, 20 Higher proportions (53%) of comorbid women were symptomatic although association between symptoms and comorbidity was 

Laboratory investigations were done for few women which was one of the limitations for this study. This is the only study where HIV status was discussed. Although statistically not significant, HIV positive women were more likely to present with symptoms compared to those who were HIV negative (55% vs 52%). Rate of lymphocytopenia was lower (20%) than that (55%/64%/80%) reported in other studies. 13, 14, 15 Only symptomatic women had lymphocytopenia however this observation was not statistically significant. The incidence of thrombocytopenia was lower (9%) when compared to another study (38%). 18 Thrombocytopenia was more (67%) common among symptomatic women although statistically not significant. High LDH (20%) was the commonest abnormality observed. This test was not reported in other studies. Unlike other studies which included laboratory results for all women irrespective of comorbidities, we excluded women with comorbid conditions as these can affect the interpretation of results such as platelet, lymphocyte and LDH counts leading to erroneous conclusion that higher number of COVID-19 infected pregnant women have abnormal laboratory results.

About 15% women had complications which was lower (21% -56%) than that of other studies. 13, 18, 19 PTL (8%), and miscarriage (2%) in this study were comparable to other studies which reported lower rate (2%, 6%) of PTL. 13, 17 However few studies reported much higher rates (41% to 47%) of PTL. 20, 21, 22 Miscarriage was found in one (2%) woman which was similar (1%) to another study. 16 Much higher (65%) rate of miscarriage was observed in another study. 20 A Chi-square test between comorbidities and maternal outcomes was not significant.

Majority (65%) had CS delivery, of which planned CS was performed to 78% of the women. CS was done for obstetrics indications. It was similar to only other study done in USA where CS rate (44%) was much lower and it was done only for obstetrics indications. 9 Mostly studies from China reported higher (86% -100%) rate of CS where COVID-19 was a routine indication for CS. 10, 11, 13, 18, 19 Reasons for performing CS for all COVID positive women were not discussed in these studies.

About 9% of neonates had complications which was higher than other studies (1%). 18 Observed fetal/neonatal outcomes in this study were 4 (6%) macerated newborn and two (3%) newborn having poor Apgar score at 5 minutes. Other studies reported lower rate (3%) of stillborn and lower rate (1%) of neonatal asphyxia. 19 , 16 A Chi-square test between comorbidities and neonatal outcomes was not significant.

This study observed higher rate (6%) of maternal deaths than that (1%) of other study. 18 There were two case studies reporting two maternal deaths. 23, 24 Maternal deaths were much higher (78%) in another report. 25 In summary, important findings in this study was that pregnant women of African ethnicity might have a low incidence of COVID-19 and its complications in comparison to other studies but may suffer from moderate to severe symptoms, preterm labor, IUGR, IUD, MSB, maternal deaths and high LDH count. In addition, mostly parous and hypertensive women in their 3 rd trimester of pregnancy contracted the disease, presenting primarily with cough. Although statistically not significant, it is clinically important to note that mostly symptomatic and comorbid women had laboratory abnormalities including higher numbers of HIV positive women were also symptomatic.

Sample size was not uniform for all variables. Laboratory testing were not done for all women. COVID testing was performed only in symptomatic women and some women undergoing CS which might lead to under-estimation of the incidence. www.mchandaids.org | © 2021 Global Health and Education Projects, Inc.

This study provided a valuable insight into the COVID-19 infection among African pregnant women and its outcome. We included all women at all level of health care facilities over a long period, in an African country which has its merit of applicability to other parts of SA and other African countries. Incidence was low. Abnormal laboratory results warrant mandatory laboratory testing for pregnant women. Infection in pregnancy among African women, regardless of the HIV status, was associated with adverse pregnancy outcomes and high maternal mortality. Large proportion (47%) of asymptomatic women raise a question if testing should be universal for all pregnant women which might be answered in further research in Africa. 

Coronavirus Disease (COVID-19) Situation Report -121

World Health Organization. Coronavirus Disease (COVID-19) Pandemic

Serial interval of COVID-19 among publicly reported confirmed cases

The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application

Mechanism of thrombocytopenia in COVID-19 patients

Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis

Guidelines on Clinical Management

National Institute for Communicable Diseases (NICD). C Guidelines for Quarantine and Isolation in Relation to COVID-19 Exposure and Infection

Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals

Pregnancy and perinatal outcomes of women with coronavirus disease (COVID-19) pneumonia: a preliminary analysis

Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records

Clinical and CT imaging features of the COVID-19 pneumonia: focus on pregnant women and children

Coronavirus disease 2019 in pregnant women: a report based on 116 cases

Government of South Africa. Minister Zweli Mkhize Confirms Total of 674 339 Cases of Coronavirus COVID-19

Ekurhuleni District: District Health Information System

Coronavirus disease 2019 (COVID-19): a systematic review of pregnancy and the possibility of vertical transmission

Analysis of maternal coronavirus infections and neonates born to mothers with 2019-ncov: a systematic review

Outcome of coronavirus spectrum infection (SARS, MERS, COVID 1 -19) during pregnancy: a systematic review and metaanalysis

Maternal and perinatal outcomes with COVID-19: A systematic review of 108 pregnancies

Coronavirus in pregnancy and delivery: rapid review

Mortality of a pregnant patient diagnosed with COVID-19: A case report with clinical, radiological, and histopathological findings

Maternal death due to COVID-19